Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects
Clinical trial NCT03905291 · COMPLETED
Trial details
- NCT number
- NCT03905291
- Sponsor
- Medy-Tox
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2018-12-26
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.